slides · global inventory
Compare Peers
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 9,820
Current window 7,531-7,560
Pages 328
Rows per page 30
Slide function
7,531-7,560 of 9,820
21
The slide explicitly notes that these are not head-to-head studies.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
25
The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
42
The slide compares monotherapy vs combination therapy clinical trial data.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
43
The slide explicitly notes that these are not head-to-head studies and differences in study design exist.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
14
The slide uses a 'preempt_rebuttal' strategy by explaining why other companies (Big Tech, Comcast, Netflix) were excluded from the peer group.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
18
Uses a structured comparison framework to preempt investor concerns regarding profitability gaps.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
25
Includes both historical trend (FY17-Q1 FY24) and peer benchmarking.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Solution (Provide relief)Loop · Mece Breakdown1 hit
35
The slide uses a stacked bar chart to show the composition of Disney's compensation and a bar chart to compare total compensation levels against peers.Disney | Shareholder Engagement Presentation Deck | 66 slides · The Walt Disney Company
Activist deck Investor relations Beat · Solution (Provide relief)1 hit
08
Etsy is highlighted in orange as #5 in the ranking.Etsy | Investor Presentation Deck | 34 slides · Etsy
Conference presentation Investor relations 1 hit
25
The slide uses two bar charts to illustrate price disparities and a callout box to show cost-saving potential.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
09
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Loop · Golden Circle1 hit
52
The slide uses a color-coded heatmap to visualize performance against criteria.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
60
The slide uses a traffic-light color coding system to highlight the superior profile of EXS4318.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
69
The table uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
85
The slide uses a heatmap-style table to visualize performance against criteria, with a specific focus on UGT1A1 inhibition risk.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
90
The table uses a heatmap-style color coding (red/green) to indicate risk levels.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
16
The table uses a color-coded heatmap (green/yellow/red/grey) to indicate performance against criteria.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
16
The slide uses a grouping strategy to compare FiscalNote against peers in different sectors, highlighting valuation multiples and recent M&A activity.FiscalNote | Results Presentation Deck | 31 slides · FiscalNote
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
The chart shows FFIC at 3.7% compared to peers ranging from 2.5% to 7.6%.Flushing Financial | Results Presentation Deck | 40 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · Financials1 hit
08
Uses the classic Branded House vs House of Brands marketing framework.Honest | Investor Presentation Deck | 31 slides · Honest
Pitch deck Investor relations Beat · Rising Success1 hit
27
The slide uses a grouped bar chart to show that Honest products have significantly lower distribution (ACV %) compared to key competitors across four product categories.Honest | Investor Presentation Deck | 31 slides · Honest
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Trojan Horse1 hit
28
The slide highlights a significant gap in shelf presence, suggesting an opportunity for growth.Honest | Investor Presentation Deck | 31 slides · Honest
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Trojan Horse1 hit
19
The slide includes a line chart showing performance over time and a summary table with specific return metrics for three different time periods.Houlihan Lokey | Investment Banking Pitch Book | 25 slides · Houlihan Lokey
Consulting deck Investment bank 1 hit
10
The slide uses a split-screen layout: left side shows social media metrics, right side highlights brand positioning.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
08
The slide uses a comparison framework to contrast standard industry benchmarks with the company's clinical data.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
13
Uses a bar chart to compare CRS duration in days across four competitors, with NXC-201 highlighted as significantly lower.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide uses a bar chart to compare neurotoxicity percentages and a table to compare clinical metrics like CRS onset and duration.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The slide highlights NXC-201's 100% overall response rate and superior cardiac response compared to CAEL-101 and Birtamimab.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
The slide uses a visual comparison of three treatment timelines to highlight the superior safety profile of NXC-201.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
29
The table compares NXC-201 against Darzalex, CAEL-101, and Birtamimab across various clinical metrics.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit